Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

This study is currently recruiting participants.

Verified January 2013 by Ohr Pharmaceutical Inc.

Sponsor:

Information provided by (Responsible Party):

Ohr Pharmaceutical Inc.

ClinicalTrials.gov Identifier:

NCT01678963

First received: August 27, 2012

Last updated: January 21, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	March 2014
Estimated Primary Completion Date:	March 2014 (Final data collection date for primary outcome measure)